ArticleFrontiers in immunology2021

Targeting the TLR2 Receptor With a Novel Thymopentin-Derived Peptide Modulates Immune Responses.

Xubiao Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.